We are an international team committed to clinical trials to improve survival without disability in newborn babies. We plan a randomised trial to confirm if bovine lactoferrin, an inexpensive dairy protein, reduces death or major morbidity and increases total breast milk intake in 1,500 very low birthweight babies in neonatal intensive care units
A Randomised Controlled Trial Of Enhanced Parenting Capacity To Improve Developmental Outcomes In Preterm Infants
Funder
National Health and Medical Research Council
Funding Amount
$1,045,141.00
Summary
In Australia there are 2, 600 very preterm survivors each year. 50% will have education/behavioural difficulties and 10% major disability. We aim to optimise the development of infants born very preterm through a tailored Positive Parenting Program. We predict reductions in child behavioural and emotional problems at 2 years corrected age.
Docosahexaenoic Acid For The Reduction Of Bronchopulomonary Dysplasia In Preterm Infants Born At Less Than 29 Weeks Gestational Age: A Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,929,854.00
Summary
A major challenge in the care of very preterm babies, is dealing with the fact that the baby has very immature lungs. They are prone to an inflammatory condition known as BPD (broncho-pulmonary dysplasia) that prevents an infant from breathing, much like asthma in older children. This can result in poor health outcomes for life. Our study will test the effect of the omega 3 fat known as DHA in reducing this inflammation in the lung and result in better outcomes for the baby.
Efficacy And Safety Of Omega-3 DHA Supplementation In Preterm Infants: Childhood Follow-up Of The N3RO Trial.
Funder
National Health and Medical Research Council
Funding Amount
$713,218.00
Summary
Giving babies born 3 to 4 months prematurely the omega-3 DHA has been thought to improve their mental development. But we don’t yet know if this is indeed so. In this follow-up study, we will be able to find out the important longer-term effects at 5-years of age of extra DHA in the first months of life by assessing the children’s mental development.
Primary Prevention Of Infant Food Allergy: A Randomised Controlled Trial Of Postnatal Vitamin D Supplementation
Funder
National Health and Medical Research Council
Funding Amount
$1,723,793.00
Summary
Low vitamin D has been linked to a range of health conditions but, unlike many countries, Australia does not recommend supplementing infants with vitamin D. Good quality research on the effectiveness of vitamin D supplementation to prevent disease is lacking. Our trial of 2330 infants examines whether a daily dose of vitamin D prevents the development of food allergy. Vitamin D is safe and low cost. Infant supplementation may be the first simple strategy to reduce this common childhood condition
M-SAKHI : Mobile Health Solutions To Help Community Providers Promote Maternal And Infant Nutrition And Health - A Community-based Cluster Randomized Controlled Trial In Rural India
Funder
National Health and Medical Research Council
Funding Amount
$2,379,427.00
Summary
The proposed research will examine the impact of the mobile phone counselling on child feeding practices, & undernutrition & cognitive development in a rural setting in India. The study aims to collect high-level evidence of whether mobile phone counselling about nutrition in pregnancy, and child feeding, directed at pregnant women and mothers in rural India will i) reduce low birthweight, ii) improve infant & child feeding, and iii) reduce child undernutrition at 24 months.
Retinal Photography To Assess Early Kidney Development In Indigenous Babies
Funder
National Health and Medical Research Council
Funding Amount
$888,098.00
Summary
The objective of this study is to identify infants who are at high risk off subsequent kidney failure . To achieve this objective, we plan to carry out comparison of kidney growth and function between Aboriginal and and non-Aboriginal infants from birth until they are 2 years old. We also hope to determine if changes in the blood vessels in these infants' eyes correspond to changes in the growing kidney- we are trying to determine if the eyes are the windows to the growing kidneys.
Characterization Of Cellular Inflammatory Responses Underlying Acute Viral Bronchiolitis In Infants
Funder
National Health and Medical Research Council
Funding Amount
$583,224.00
Summary
This project seeks to characterize the inflammatory mechanisms triggered during severe respiratory virus infections that result in hospitalization of infants. These are associated with later development of asthma. We aim to identify new molecular targets for anti-inflammatory drug development, with the long term goals of improving treatment for acute disease, and prevention of subsequent asthma.
A Pre-clinical Trial Of Early Blood Transfusion For Improving Cerebral Oxygen Delivery In Very Preterm Neonates
Funder
National Health and Medical Research Council
Funding Amount
$970,603.00
Summary
Long-term disability is common in babies born prematurely. This may be due to insufficient delivery of oxygen to the brain, but currently there is no treatment that increases oxygen delivery to the brain. We will determine if blood transfusion is more effective than current treatments given to prevent brain injury in preterm babies. Transfusion has two benefits. It will increase the amount of blood going to the brain. It will also increase the amount of oxygen carried by the blood.
Human Malarial Immunity And Risk Of Malaria Post-partum And During Infancy
Funder
National Health and Medical Research Council
Funding Amount
$263,079.00
Summary
Malaria is a major cause of morbidity and mortality worldwide, particularly in children and pregnant women. This project aims to understand and identify immune responses that protect pregnant women and infants from malaria. This knowledge is critical to understanding immunity to malaria in high risk groups and for the development and use of vaccines to protect pregnant women and their babies.